{"organizations": [], "uuid": "fb4cebfd6af212cd01a12c339d9a9e1742d5e997", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-genocea-files-ind-for-neoantigen-c/brief-genocea-files-ind-for-neoantigen-cancer-vaccine-candidate-gen-009-idUSFWN1S70ZL", "country": "US", "domain_rank": 408, "title": "BRIEF-Genocea Files IND For Neoantigen Cancer Vaccine Candidate Gen-009", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-30T16:38:00.000+03:00", "replies_count": 0, "uuid": "fb4cebfd6af212cd01a12c339d9a9e1742d5e997"}, "author": "", "url": "https://www.reuters.com/article/brief-genocea-files-ind-for-neoantigen-c/brief-genocea-files-ind-for-neoantigen-cancer-vaccine-candidate-gen-009-idUSFWN1S70ZL", "ord_in_thread": 0, "title": "BRIEF-Genocea Files IND For Neoantigen Cancer Vaccine Candidate Gen-009", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "genocea biosciences inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 30, 2018 / 1:40 PM / Updated 10 minutes ago BRIEF-Genocea Files IND For Neoantigen Cancer Vaccine Candidate Gen-009 Reuters Staff 1 Min Read\nApril 30 (Reuters) - Genocea Biosciences Inc:\n* GENOCEA - FILES IND FOR NEOANTIGEN CANCER VACCINE CANDIDATE GEN-009, PLANS TO INITIATE PHASE 1/2A CLINICAL PROGRAM LATER THIS YEAR\n* GENOCEA - TOP-LINE IMMUNE RESPONSE DATA FROM STUDY EXPECTED IN THE FIRST HALF OF 2019 Source text: ( bit.ly/2r7ztW4 ) Further company coverage:", "external_links": ["https://bit.ly/2r7ztW4"], "published": "2018-04-30T16:38:00.000+03:00", "crawled": "2018-04-30T17:00:47.011+03:00", "highlightTitle": ""}